Published in
Taylor and Francis Group, Expert Opinion on Emerging Drugs, 4(16), p. 697-712, 2011
DOI: 10.1517/14728214.2011.642861
Links
Tools
Emerging oral drugs for relapsing–remitting multiple sclerosis
Journal article published in 2011 by
Claudio Gasperini 
,
Serena Ruggieri
,
Serena Ruggieri
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 